Molecular network of colorectal cancer and current therapeutic options

Z Huang, M Yang - Frontiers in oncology, 2022 - frontiersin.org
Colorectal cancer (CRC), a leading cause of cancer-related mortalities globally, results from
the accumulation of multiple genetic and epigenetic alterations in the normal colonic and …

Clinical impact of exosomes in colorectal cancer metastasis

S Ghosh, R Dhar, G Gurudas Shivji, D Dey… - ACS Applied Bio …, 2023 - ACS Publications
Cancer is a complex deadly disease that has caused a global health crisis in recent epochs.
Colorectal cancer (CRC) is the third most common malignant gastrointestinal disease. It has …

Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis

X Guo, Q Zhou, D Su, Y Luo, Z Fu, L Huang, Z Li… - Molecular cancer, 2020 - Springer
Background Accumulating evidence suggests that circular RNAs (circRNAs) are important
participants in cancer progression. However, the biological processes and underlying …

The versatile roles of cancer-associated fibroblasts in colorectal cancer and therapeutic implications

L Deng, N Jiang, J Zeng, Y Wang, H Cui - Frontiers in Cell and …, 2021 - frontiersin.org
The tumor microenvironment (TME) is populated by abundant cancer-associated fibroblasts
(CAFs) that radically influence the disease progression across many cancers, including the …

CREB5 promotes invasiveness and metastasis in colorectal cancer by directly activating MET

S Wang, J Qiu, L Liu, C Su, L Qi, C Huang… - Journal of Experimental …, 2020 - Springer
Background cAMP responsive element binding protein 5 (CREB5) is a transcriptional
activator in eukaryotic cells that can regulate gene expression. Previously, we found that …

The role of the tumor microenvironment in colorectal cancer and the potential therapeutic approaches

N Zafari, F Khosravi, Z Rezaee… - Journal of Clinical …, 2022 - Wiley Online Library
Background Colorectal cancer (CRC) with a high prevalence is recognized as the fourth
most common cause of cancer‐related death globally. Over the past decade, there has been …

Recent advances in targeted drug delivery systems for resistant colorectal cancer

M Sharifi-Azad, M Fathi, WC Cho, A Barzegari… - Cancer Cell …, 2022 - Springer
Colorectal cancer (CRC) is one of the deadliest cancers in the world, the incidences and
morality rate are rising and poses an important threat to the public health. It is known that …

Roles of MET in human cancer

X Yang, HY Liao, HH Zhang - Clinica Chimica Acta, 2022 - Elsevier
The MET proto-oncogene was first identified in osteosarcoma cells exposed to carcinogens.
Although expressed in many normal cells, MET is overexpressed in many human cancers …

Targeting MET Amplification: Opportunities and Obstacles in Therapeutic Approaches

Y Kumaki, G Oda, S Ikeda - Cancers, 2023 - mdpi.com
Simple Summary The MET gene is crucial for cell growth and has shown promise as a
cancer treatment target. However, distinguishing between focal amplification and polysomy …

Pancreatic cancer and platelets crosstalk: a potential biomarker and target

S Mai, I Inkielewicz-Stepniak - Frontiers in cell and developmental …, 2021 - frontiersin.org
Platelets have been recognized as key players in hemostasis, thrombosis, and cancer.
Preclinical and clinical researches evidenced that tumorigenesis and metastasis can be …